![]() GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. | ![]() Theravance Biopharma Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses. | ![]() Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. | |||
Founding Date | Founding Date 2003 | Founding Date 2003 | Founding Date 2012 | Founding Date 1996 | Founding Date 2005 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ Zug, CH | Locations South San Francisco, US HQ Planegg, DE Amsterdam, NL | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations Dublin, IE HQ San Francisco, US | Locations Rockville, US HQ |
Employees | Employees 23737% increase | Employees 32429% increase | Employees 352106% increase | Employees 158 | Employees 5752% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) 784.2 m | Valuation ($) 2.2 b |
Twitter followers | Twitter followers 2 k | Twitter followers 951 | Twitter followers 2.1 k | Twitter followers N/A | Twitter followers 263 |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank N/A | Alexa Website Rank 422663 | Alexa Website Rank 524195 | Alexa Website Rank 555058 |
Employee Rating | Employee Rating 4.9 | Employee Rating 3.5 | Employee Rating 4.3 | Employee Rating 3.5 | Employee Rating 3.3 |
Financial | |||||
Revenue (est.) | Revenue (est.) $92.5m (FY, 2020) | Revenue (est.) $116.6m (FY, 2019) | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $55.3m (FY, 2021) | Revenue (est.) $579.8m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods $44.4m (FY, 2019) | Cost of goods $3.3m (FY, 2021) | Cost of goods N/A | Cost of goods $75.1m (FY, 2021) |
Gross profit | Gross profit N/A | Gross profit $72.3m (FY, 2019) | Gross profit N/A | Gross profit $55.3m (FY, 2021) | Gross profit $504.7m (FY, 2021) |
Net income | Net income ($166m) (FY, 2020) | Net income ($290.7m) (FY, 2019) | Net income ($303.1m) (FY, 2021) | Net income ($199.4m) (FY, 2021) | Net income $53.4m (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 141.8m | Total funding raised $ 295.1m | Total funding raised $ 88.7m | Total funding raised $ 55m | Total funding raised $ 69.5m |
Portola Pharmaceuticals is a biopharmaceutical company.
View companyGBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyTheravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses.
View companySupernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View company